By Susanna Moon
Chicago, April 30 - Orexo AB said it priced a four-year senior bond loan at Stibor plus 400 basis points.
The bond loan has a total framework amount of SEK 1 billion, and Orexo plans to apply to list the bonds on Nasdaq OMX Stockholm, according to a company press release.
Pareto Securities AB is the bookrunner.
"We are very pleased with the solid interest for the bond amongst investors. The issue strengthens our financial position further and is an important step in financing the continued expansion of Zubsolv, as well as to decrease current bank debt," Nikolaj Sorensen, president and chief executive officer of Orexo, said in the press release.
Orexo is a specialty pharma company based in Uppsala, Sweden.
| Issuer: | Orexo AB
|
| Issue: | Senior bond loan
|
| Amount: | SEK 500 million
|
| Maturity: | May 9, 2018
|
| Bookrunner: | Pareto Securities AB
|
| Coupon: | Stibor plus 400 bps
|
| Trade date: | April 30
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
